A-286501

Pharmaceutical compound

A-286501
Identifiers

IUPAC name (1S,2R,3S,5R)-3-amino-5-(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol
CAS Number	483341-15-7
PubChem CID	9862222
ChemSpider	8037918
UNII	8G293B8TT7
Chemical and physical data
Formula	C₁₁H₁₄BrN₅O₂
Molar mass	328.170g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C1[C@@H]([C@H]([C@H]([C@@H]1N2C=C(C3=C(N=CN=C32)N)Br)O)O)N
InChI InChI=1S/C11H14BrN5O2/c12-4-2-17(6-1-5(13)8(18)9(6)19)11-7(4)10(14)15-3-16-11/h2-3,5-6,8-9,18-19H,1,13H2,(H2,14,15,16)/t5-,6+,8+,9-/m0/s1 Key:FKFYQPGMXTXSTC-LWIVVEGESA-N

A-286501 is an experimental drug that acts as a selective inhibitor of the enzyme adenosine kinase. In animal studies it has analgesic and antiinflammatory effects.^[1]^[2]^[3]

References

↑ Fleurisson C, Benedetti E, Micouin L (2021). "Cyclic cis-1,3-Diamines Derived from Bicyclic Hydrazines: Synthesis and Applications" (PDF). Synlett. 32 (9): 858–874. doi:10.1055/s-0040-1707324.
↑ Jarvis MF, Yu H, McGaraughty S, Wismer CT, Mikusa J, Zhu C, et al. (March 2002). "Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor". Pain. 96 (1–2): 107–118. doi:10.1016/s0304-3959(01)00435-3. PMID 11932067.
↑ Jarvis MF, Mikusa J, Chu KL, Wismer CT, Honore P, Kowaluk EA, et al. (October 2002). "Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats". Pharmacology, Biochemistry, and Behavior. 73 (3): 573–581. doi:10.1016/s0091-3057(02)00840-7. PMID 12151032.

This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information.